Molecular cytogenetics involves the combination of molecular biology and cytogenetics. It involves use of various reagents which helps to properly distinguish normal and cancer causing cells. Molecular cytogenetics is a useful tool for diagnosing and treatment of various malignancies such as brain tumors, haematological malignancies etc.
The growth of global molecular cytogenetics market is expected to be majorly driven by increasing prevalence and incidence of genetic syndromes, geriatric population and rising number of chronic diseases in the global population. Various technological developments, availability of emerging technologies in the healthcare industry are expected to be a major opportunity for players in the global molecular cytogenetics market.
The "Global Molecular Cytogenetics Market Analysis to 2025" is a specialized and in-depth study of biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global molecular cytogenetics market with detailed market segmentation by product, application, end user and geography. The global molecular cytogenetics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global molecular cytogenetics market is segmented on the basis of product, application, end user and geography. The product segment includes, Consumables, software & services and instruments. Based on application, the market is segmented as, oncology, personalized medicine, genetic disorder, others. Based on end user, the market is segmented as, hospitals, clinical & research laboratories, academic research institutes, pharmaceutical and biotechnology companies and others.
The molecular cytogenetics market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global molecular cytogenetics market based on product, application, end user and geography. It also provides market size and forecast till 2025 for overall molecular cytogenetics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America holds a dominant position in the global molecular cytogenetics market which is attributed to the improved healthcare infrastructure and rising number of cardiovascular disorders, aging problem and occurrence of major key players in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry, enduring workshop in Asian countries such as, India, China and Japan.
The molecular cytogenetics market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The molecular cytogenetics market report also includes the profiles of key molecular cytogenetics market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Danaher, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd, Applied Spectral Imaging, Agilent and Abbott among others.